ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunities Listed

March 13, 2009

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

AACI Opposes Most Guidelines Proposals But Can’t Agree On Research Based Ceiling

May 2, 1980

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994